The Dangers of Investing for Homeruns
Investing can be an emotional process. Placing your hard-earned money somewhere in the hopes that...
Read MoreOct 26, 2021
Investing can be an emotional process. Placing your hard-earned money somewhere in the hopes that...
Read MoreOct 26, 2021
A systematic review of 24 real-world observational studies in adult patients with severe allergic...
Read MoreOct 26, 2021
Exacerbation rates and forced expiration volume (FEV1) improvements with omalizumab treatment were...
Read MoreOct 25, 2021
The anti-immunoglobulin (IgE) monoclonal antibody omalizumab proved beneficial for all patients...
Read MoreOct 25, 2021
Physicians by nature are often great scholars. Continuing education is vital to maintaining...
Read MoreOct 25, 2021
Magnetic resonance imaging (MRI) and clinical characteristics could differentiate between...
Read MoreOct 22, 2021
New research was presented at CHEST 2021, the virtual Annual International Scientific Assembly of...
Read MoreOct 22, 2021
If you’re a physician looking to leave medicine or simply supplement your income with a side...
Read MoreOct 22, 2021
To prevent pay cuts to physicians, last week, Representatives Ami Bera, MD, (D-CA) and Larry...
Read MoreOct 21, 2021
Most patients with neurovascular age-related macular degeneration (nAMD) would not qualify for the trials that inform currents standards of care, according to a study presented at the 39th Annual Scientific Meeting of ASRS 2021...
Read MoreOct 21, 2021
Only one-third of Medicare beneficiaries with neovascular age-related macular degeneration (nAMB) were “persistent” with anti-VEGF monotherapy treatment each year, according to a study presented at the 39th Annual Scientific...
Read MoreOct 21, 2021
Geographic disparities in access to clinical trial sites exist for neovascular age-related macular degeneration (nAMD) in the United States, according to a study presented at the 38th Annual Scientific Meeting of the American...
Read MoreOct 21, 2021
Investigators sought to assess the impact of telerehabilitation in patients with MS during the isolation period of the COVID-19 pandemic. They conducted a retrospective analysis using medical records from adults with MS and...
Read MoreOct 21, 2021
Data presented at prior CMSC meetings described baseline, 1-year, and 2-year results of the Multiple Sclerosis Achievement Center, which assessed day wellness programs targeting physical, cognitive, and social well-being in...
Read MoreOct 21, 2021
The lack of behavioral interventions that aim to increase physical activity (PA) among individuals with fatigue prompted researchers to examine variables of social cognitive theory (SCT) as correlates of PA among adult patients...
Read MoreOct 21, 2021
Research demonstrates that Black Americans with MS experience more aggressive disease and a higher lesion burden when compared with White Americans, but the factors associated with these disparities have not been examined. To...
Read MoreOct 21, 2021
While COVID-19 vaccines are recommended for people with neuromyelitis optica spectrum disorder (NMOSD) and MOG-antibody-associated disease (MOGAD), they were not specifically tested in this population, and thus, have an unclear...
Read MoreOct 21, 2021
Investigators reported final safety and efficacy data from the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder (NMOSD), in which patients aged 18 and older who had an Expanded Disability Status Scale...
Read MoreOct 21, 2021
Previous studies have examined the platelet-to-lymphocyte (PLR) and neutrophil-to-lymphocyte (NLR) ratios as biomarkers of inflammation and disease activity in autoimmune diseases. Researchers assessed the ability of these...
Read MoreOct 21, 2021
Using a propensity score-matching methodology, investigators examined the economic and healthcare burden of neuromyelitis optica spectrum disorder (NMOSD). The study team performed a retrospective analysis of two claims datasets...
Read More